iPSCs directed to differentiate into
specific cell types offer the possibility of a renewable source of replacement cells and tissues to treat ailments, including Parkinson's disease, spinal cord injury, heart disease, diabetes, and arthritis.
Furthermore, besides
offering valuable insight into the function of this novel RNA
type, the researchers also believe that the findings will open new avenues for novel treatments in which
cell -
specific enhancer sequences can be targeted to alter gene expression.